Laboratory of Reproductive Biology, Rigshospitalet, University Hospital of Copenhagen, 2100 Copenhagen, Denmark.
Department of Urology, Aksaray University School of Medicine, Aksaray 68100, Turkey.
Int J Mol Sci. 2019 Oct 29;20(21):5390. doi: 10.3390/ijms20215390.
Spermatogonial stem cell (SSC) transplantation therapy is a promising strategy to renew spermatogenesis for prepubertal boys whose fertility is compromised. However, propagation of SSCs is required due to a limited number of SSCs in cryopreserved testicular tissue. This propagation must be done under xeno-free conditions for clinical application. SSCs were propagated from infant testicular tissue (7 mg and 10 mg) from two boys under xeno-free conditions using human platelet lysate and nutrient source. We verified SSC-like cell clusters (SSCLCs) by quantitative real-time polymerase chain reaction (PCR) and immune-reaction assay using the SSC markers undifferentiated embryonic cell transcription factor 1 (UTF1), ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1), GDNF receptor alpha-1 (GFRα-1) Fα and promyelocytic leukaemia zinc finger protein (PLZF). The functionality of the propagated SSCs was investigated by pre-labelling using green fluorescent Cell Linker PKH67 and xeno-transplantation of the SSCLCs into busulfan-treated, therefore sterile, immunodeficient mice. SSC-like cell clusters (SSCLCs) appeared after 2 weeks in primary passage. The SSCLCs were SSC-like as the UTF1, UCHL1, GFRα1 and PLZF were all positive. After 2.5 months' culture period, a total of 13 million cells from one sample were harvested for xenotransplantation. Labelled human propagated SSCs were identified and verified in mouse seminiferous tubules at 3-6 weeks, confirming that the transplanted cells contain SSCLCs. The present xeno-free clinical culture protocol allows propagation of SSCs from infant boys.
精原干细胞(SSC)移植疗法是一种有前途的策略,可以为生育能力受损的青春期前男孩更新精子发生。然而,由于冷冻保存的睾丸组织中 SSC 的数量有限,因此需要进行 SSC 的增殖。为了临床应用,这种增殖必须在无动物源条件下进行。我们使用人血小板裂解液和营养源,从两个男孩的婴儿睾丸组织(7 毫克和 10 毫克)中,在无动物源条件下增殖 SSC。我们通过使用 SSC 标记物未分化胚胎细胞转录因子 1(UTF1)、泛素羧基末端水解酶同工酶 L1(UCHL1)、GDNF 受体 alpha-1(GFRα-1)Fα和早幼粒细胞白血病锌指蛋白(PLZF)的定量实时聚合酶链反应(PCR)和免疫反应检测来验证 SSC 样细胞簇(SSCLC)。通过使用绿色荧光 Cell Linker PKH67 进行预标记,并将 SSCLCs 异种移植到接受白消安处理的无菌免疫缺陷小鼠中,来研究增殖的 SSC 的功能。在原代培养第 2 周后出现了 SSC 样细胞簇(SSCLC)。SSCLC 是 SSC 样的,因为 UTF1、UCHL1、GFRα1 和 PLZF 均为阳性。经过 2.5 个月的培养期,从一个样本中收获了总共 1300 万个细胞进行异种移植。在 3-6 周时,在小鼠曲细精管中鉴定和验证了标记的人源性增殖 SSC,证实移植细胞含有 SSCLC。本无动物源临床培养方案允许从婴儿男孩中增殖 SSC。